Department of Radiology
Found 259 results
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
2024
Mehta NH, Wang X, Keil SA, Xi K, Zhou L, Lee K, Tan W, Spector E, Goldan A, Kelly J et al..  2024.  [1-11C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjects.. Fluids Barriers CNS. 21(1):30.
Mosconi L, Williams S, Carlton C, Zarate C, Boneu C, Fauci F, Ajila T, Nerattini M, Jett S, Andy C et al..  2024.  Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's risk.. Sci Rep. 14(1):5519.
2023
Shahidi R, Baradaran M, Asgarzadeh A, Bagherieh S, Tajabadi Z, Farhadi A, Korani SSotoudehni, Khalafi M, Shobeiri P, Sadeghsalehi H et al..  2023.  Diagnostic performance of MRI radiomics for classification of Alzheimer's disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis.. Aging Clin Exp Res. 35(11):2333-2348.
Javitt DC, Martinez A, Sehatpour P, Beloborodova A, Habeck C, Gazes Y, Bermudez D, Razlighi QR, Devanand DP, Stern Y.  2023.  Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment.. Alzheimers Res Ther. 15(1):42.
Hojjati SHani, Butler TA, Chiang GC, Habeck C, RoyChoudhury A, Feiz F, Shteingart J, Nayak S, Ozoria S, Fernández A et al..  2023.  Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness.. Neuroimage Clin. 38:103409.
Jett S, Dyke JP, Yepez CBoneu, Zarate C, Carlton C, Schelbaum E, Jang G, Pahlajani S, Williams S, Brinton RDiaz et al..  2023.  Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.. PLoS One. 18(2):e0281302.
Pirraglia E, Glodzik L, Shao Y.  2023.  Lower mortality risk in APOE4 carriers with normal cognitive ageing.. Sci Rep. 13(1):15089.
Madhav H, Abdel-Rahman SA, Hashmi MAmiruddin, Rahman MAtaur, Rehan M, Pal K, Nayeem SM, Gabr MT, Hoda N.  2023.  Multicomponent Petasis reaction for the identification of pyrazine based multi-target directed anti-Alzheimer's agents: In-silico design, synthesis, and characterization.. Eur J Med Chem. 254:115354.
Mehta NH, Zhou L, Li Y, McIntire LBeth, Nordvig A, Butler T, de Leon M, Chiang GC.  2023.  Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline.. Sci Rep. 13(1):8847.
2022
Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, P Mozley D, Nehmeh S, Pahlajani S, Wang X et al..  2022.  Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.. Fluids Barriers CNS. 19(1):21.
Wegiel J, Flory M, Kuchna I, Nowicki K, Wegiel J, Ma SYong, Zhong N, Bobrowicz TWierzba, de Leon M, Lai F et al..  2022.  Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.. Acta Neuropathol Commun. 10(1):2.
Petersen GCassinelli, Roytman M, Chiang GC, Li Y, Gordon ML, Franceschi AM.  2022.  Overview of tau PET molecular imaging.. Curr Opin Neurol. 35(2):230-239.
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJelle, Aarsland D, Alcolea D, Altomare D, von Arnim C et al..  2022.  Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.. JAMA Neurol. 79(3):228-243.
Jett S, Dyke JP, Andy C, Schelbaum E, Jang G, Yepez CBoneu, Pahlajani S, Diaz I, Brinton RDiaz, Mosconi L.  2022.  Sex and menopause impact 31P-Magnetic Resonance Spectroscopy brain mitochondrial function in association with 11C-PiB PET amyloid-beta load.. Sci Rep. 12(1):22087.
2021
Schelbaum E, Loughlin L, Jett S, Zhang C, Jang G, Malviya N, Hristov H, Pahlajani S, Isaacson R, Dyke JP et al..  2021.  Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife.. Neurology. 97(23):e2328-e2339.
Wegiel J, Flory M, Kuchna I, Nowicki K, Ma SYong, Wegiel J, Badmaev E, de Leon M, Wisniewski T, Reisberg B.  2021.  Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease.. J Neuropathol Exp Neurol. 80(1):21-44.
Hategan SI, Kamer SA, Craig RG, Sinescu C, de Leon MJ, Jianu DC, Marian C, Bora BI, Dan T-F, Birdac CD et al..  2021.  Cognitive dysfunction in young subjects with periodontal disease.. Neurol Sci. 42(11):4511-4519.
Rashid T, Abdulkadir A, Nasrallah IM, Ware JB, Liu H, Spincemaille P, J Romero R, R Bryan N, Heckbert SR, Habes M.  2021.  DEEPMIR: a deep neural network for differential detection of cerebral microbleeds and iron deposits in MRI.. Sci Rep. 11(1):14124.
Manzoor S, Prajapati SKumar, Majumdar S, Raza MKausar, Gabr MT, Kumar S, Pal K, Rashid H, Kumar S, Krishnamurthy S et al..  2021.  Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.. Eur J Med Chem. 215:113224.
Manzoor S, Gabr MT, Rasool B, Pal K, Hoda N.  2021.  Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease.. Bioorg Chem. 116:105354.
Mosconi L, Berti V, Dyke J, Schelbaum E, Jett S, Loughlin L, Jang G, Rahman A, Hristov H, Pahlajani S et al..  2021.  Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.. Sci Rep. 11(1):10867.
Palta P, Rippon B, Tahmi M, Sherwood G, Soto L, Ceballos F, Laing K, He H, Reitz C, Razlighi Q et al..  2021.  Metabolic syndrome and its components in relation to in vivo brain amyloid and neurodegeneration in late middle age.. Neurobiol Aging. 97:89-96.
Pascoal TA, Benedet AL, Ashton NJ, Kang MSu, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK et al..  2021.  Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(9):1592-1599.
Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS.  2021.  Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.. Contemp Clin Trials. 107:106488.
Matthews DC, Mao X, Dowd K, Tsakanikas D, Jiang CS, Meuser C, Andrews RD, Lukic AS, Lee J, Hampilos N et al..  2021.  Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.. Brain. 144(12):3742-3755.